If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarget Healthc. Regulatory News (THRL)

Share Price Information for Target Healthc. (THRL)

Share Price is delayed by 15 minutes
Get Live Data
110.00    -0.80 (-0.72%)
Bid:
109.60
Ask:
110.00
Spread: 0.40 (0.365%)
Market Cap: £682.26m
THRL Live PriceLast checked at - London Stock Exchange

Intraday Target Healthc. Share Chart

Director/PDMR Shareholding

13 May 2016 12:00

RNS Number : 2180Y
Target Healthcare REIT Limited
13 May 2016
 

Annex DTR3

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 Please complete all relevant boxes in block capital letters.

 1.

Name of the issuer

TARGET HEALTHCARE REIT LIMITED

 2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act (2006), or (iii) in accordance with paragraph 26 of the Model Code

 DTR 3.1.2.R

 3.

Name of person discharging managerial responsibilities/director

 

THOMAS J. HUTCHISON III

 4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

AS 3 

 5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

AS IN 3 ABOVE

 6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

ORDINARY SHARES

 7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

AS IN 3 ABOVE

 8.

State the nature of the transaction

 

PURCHASE OF ORDINARY SHARES

 9.

Number of shares, debentures or financial instruments relating to shares acquired

10,000

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.004% 

 11.

Number of shares, debentures or financial instruments relating to shares disposed

 -

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 - 

 13.

Price per share or value of transaction

105.0 PENCE PER SHARE

 

14.

 

Date and place of transaction

 

 

12 MAY 2016, LONDON

 15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

70,000 (0.028%) 

16.

Date issuer informed of transaction

 

 

 

 

12 MAY 2016

 If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17.

Date of grant

18.

Period during which or date on which exercisable

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

23.

Any additional information

24.

Name of contact and telephone number for queries

 MARTIN CASSELS, 0131 550 3760

 

Name of authorised officer of issuer responsible for making notification

MARTIN CASSELS 

Date of notification 13 MAY 2016

Notes: This form is intended for use by an issuer to make a RIS notification required by DTR 3.1.4.

 (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFIFSDFMSEFI
Date   Source Headline
30th Nov 20237:00 amRNSResult of AGM
7th Nov 202310:16 amEQSEdison issues outlook on Target Healthcare REIT (THRL): DPS growth from a sustainable base
1st Nov 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
31st Oct 20235:30 pmRNSAnnual Financial Report
10th Oct 20237:00 amRNSFinal Results
4th Oct 20232:00 pmRNSNotice of Full Year Results
11th Aug 20238:09 amRNSEdison issues update on Target Healthcare REIT
2nd Aug 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
3rd May 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Mar 202311:37 amRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSHalf-year Report
27th Mar 20237:00 amRNSDisposal of four care homes in Northern Ireland
23rd Mar 20237:00 amRNSNotice of Half Year Results
17th Feb 202311:08 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
7th Dec 20227:00 amRNSDirectorate Change
6th Dec 20222:30 pmRNSResult of AGM
21st Nov 20225:07 pmRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
8th Nov 20225:47 pmRNSAnnual Financial Report
2nd Nov 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Oct 20229:17 amRNSHolding(s) in Company
17th Oct 20229:20 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSFinal Results
12th Oct 20227:00 amRNSDirectorate Change
1st Sep 20227:00 amRNSPortfolio Update
4th Aug 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
22nd Jun 20227:00 amRNSHolding(s) in Company
9th Jun 20226:01 pmRNSHolding(s) in Company
9th Jun 20227:00 amRNSInclusion in FTSE 250 Index
6th Jun 20229:42 amRNSHolding(s) in Company
9th May 202211:43 amRNSDirector/PDMR Shareholding
5th May 202210:01 amRNSHolding(s) in Company
5th May 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
3rd May 20229:21 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSHalf-year Report
10th Mar 20227:00 amRNSNotice of Half Year Results
1st Feb 20227:00 amRNSDirectorate Change
27th Jan 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
20th Dec 20217:00 amRNSCompletion of Portfolio Acquisition
15th Dec 20217:00 amRNSResult of AGM
30th Nov 20217:00 amRNSNew long-term institutional debt facility
10th Nov 20219:00 amRNSAnnual Financial Report
3rd Nov 20217:00 amRNSNet Asset Value, Corporate Update & Dividend
20th Oct 20217:00 amRNSFinal Results
18th Oct 20217:00 amRNSNotice of Full Year Results
1st Oct 20219:00 amRNSTotal Voting Rights
9th Sep 20217:00 amRNSIncrease in Issue Size
26th Aug 20212:12 pmRNSProposed Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.